Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SENP1 | Q9P0U3 | 1/20 | 0.50 |
| ▸ | USP7 | Q93009 | 7/20 | 0.49 |
| ▸ | ESR2 | Q92731 | 4/20 | 0.44 |
| ▸ | ESR1 | P03372 | 4/20 | 0.42 |
| ▸ | MGAM | O43451 | 2/20 | 0.42 |
| ▸ | GAA | P10253 | 2/20 | 0.42 |
| ▸ | SI | P14410 | 2/20 | 0.42 |
| ▸ | MGAM2 | Q2M2H8 | 2/20 | 0.42 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.42 |
| ▸ | MMP2 | P08253 | 1/20 | 0.40 |
| ▸ | MMP3 | P08254 | 1/20 | 0.40 |
| ▸ | ACHE | P22303 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4367504 | 0.89 | SENP1 (0.61) | SENP1USP7ESR2ESR1HSD17B1 | |
| SCHEMBL29929295 | 0.89 | SENP1 (0.61) | SENP1USP7ESR2ESR1HSD17B1 | |
| SCHEMBL28958011 | 0.86 | ESR1 (0.56) | SENP1USP7ESR2ESR1MGAM | |
| SCHEMBL11592257 | 0.85 | USP7 (0.56) | SENP1USP7ESR2ESR1MGAM | |
| SCHEMBL11206535 | 0.85 | SENP1 (0.54) | SENP1USP7ESR2ESR1MGAM | |
| SCHEMBL9541037 | 0.85 | SENP1 (0.54) | SENP1USP7ESR2ESR1MGAM | |
| SCHEMBL68749 | 0.81 | SENP1 (0.48) | SENP1USP7ESR2ESR1MGAM | |
| SCHEMBL11442989 | 0.77 | HSD17B10 (0.47) | SENP1USP7ESR2ESR1MGAM | |
| SCHEMBL11573641 | 0.77 | ESR2 (0.47) | ESR2HSD17B10 | |
| SCHEMBL13119867 | 0.77 | BCL2L1 (0.64) | USP7ESR2ESR1MMP3HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 880 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2655383-A2 | HYPERBRANCHED OLIGOMERIC PHOSPHONATES AND COMPOSITIONS INCLUDING THE SAME | FRX Polymers, Inc. (US) | 2013-10-30 | — | — | EP | claimed |
| US-8530044-B2 | Hyperbranched oligomeric phosphonates and compositions including the same | FRX POLYMERS, INC. (US) | 2013-09-10 | — | — | US | claimed |
| US-20120171460-A1 | HYPERBRANCHED OLIGOMERIC PHOSPHONATES AND COMPOSITIONS INCLUDING THE SAME | FRX POLYMERS, INC. (US) | 2012-07-05 | — | — | US | claimed |
| WO-2012088435-A2 | HYPERBRANCHED OLIGOMERIC PHOSPHONATES AND COMPOSITIONS INCLUDING THE SAME | FRX POLYMERS, INC. (US) | 2012-06-28 | — | — | WO | claimed |
| US-7208564-B2 | Branched polyformals and copolyformals their preparation and use | BAYER MATERIALSCIENCE AG (DE) | 2007-04-24 | — | — | US | claimed |
| US-5470937-A | Liquid crystals | IDEMITSU PETROCHEMICAL CO., LTD. (JP) | 1995-11-28 | — | — | US | claimed |
| US-5112936-A | Impact resistant polycarbonates for blow molding | IDEMITSU PETROCHEMICAL CO., LTD. (JP) | 1992-05-12 | — | — | US | claimed |
| US-5041523-A | Interfacial polycondensation using divalent phenol and branching agent | IDEMITSU PETROCHEMICAL CO., LTD. (JP) | 1991-08-20 | — | — | US | claimed |
| EP-0021260-B2 | Process for the preparation of thermoplastic, branched, aromatic polyphosphonates | BAYER AG (DE) | 1989-04-19 | — | — | EP | claimed |
| US-4582893-A | Aromatic polyesters which contain terminal or lateral radicals with two conjugated double bonds | BAYER AKTIENGESELLSCHAFT (DE) | 1986-04-15 | — | — | US | claimed |
| US-4415719-A | HEAT-RESISTANT FIREPROOFING MOLDING MATERIALS; USING A BASIC CATALYST, A DIARYL PHOSPHONATE AND AROMATIC POLYHYDROXY COMPOUND | BAYER AKTIENGESELLSCHAFT (DE) | 1983-11-15 | — | — | US | claimed |
| EP-0021260-B1 | Process for the preparation of thermoplastic, branched, aromatic polyphosphonates | BAYER AG (DE) | 1983-04-13 | — | — | EP | claimed |
| WO-2026099070-A2 | BLENDS OF THERMOPLASTIC POLYMERS WITH COVALENT ADAPTABLE NETWORKS | COVESTRO DEUTSCHLAND AG (DE) | 2026-05-15 | — | — | WO | disclosed |
| US-20260132906-A1 | OVER MOULDED LED MODULE WITH INTEGRATED HEATSINK AND OPTIC | LUMILEDS LLC (US) | 2026-05-14 | — | — | US | disclosed |
| US-12625517-B2 | Clamshell housing for human-machine interface (HMI) | COVESTRO LLC (US) | 2026-05-12 | — | — | US | disclosed |
| EP-4735527-A1 | POLYCARBONATE COMPOSITION | Covestro Deutschland AG (DE) | 2026-05-06 | — | — | EP | disclosed |
| US-4202949-A | BISPHENOL POLYCARBONATE POLYMERIZED WITH A BLOCK POLYMER OF A VINYL AROMATIC AND A CONJUGATED DIENE, THERMAL STABILITY | BAYER AKTIENGESELLSCHAFT (DE) | 1980-05-13 | — | — | US | disclosed |
| US-4146587-A | SEGMENT POLYMERS DERIVED FROM AROMATIC VINYL-DIENE BLOCK POLYMER ANION AND AROMATIC POLYCARBONATE | BAYER AKTIENGESELLSCHAFT (DE) | 1979-03-27 | — | — | US | disclosed |
| US-4009148-A | High molecular weight polycarbonates of α,α,α,α',α',α'-hexakisaryl-1,3-and/or -1,4-dimethyl benzenes | BAYER AKTIENGESELLSCHAFT (DT) | 1977-02-22 | — | — | US | disclosed |
| US-3978159-A | POLYCARBONATES | BAYER AKTIENGESELLSCHAFT (DT) | 1976-08-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12625517-B2 | Clamshell housing for human-machine interface (HMI) | CTCF, MAP2, MTCL3 | SENP1 1397/4885USP7 333/4885ESR2 2973/4885 |
| US-20260132906-A1 | OVER MOULDED LED MODULE WITH INTEGRATED HEATSINK AND OPTIC | HEATR6, THUMPD1, CFAP20 | SENP1 1446/4885USP7 1459/4885ESR2 4016/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.